ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

IQVIA at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

IQVIA takes part in 3 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1001. Its work focuses on treatment decisions and patient evidence in cancer care. It examines factors that may guide first treatment for head and neck cancer and how patient-reported outcomes affect reimbursement decisions.

OrganizationESMO 2026 Attendance
CRO & servicesExhibitor
Global contract research and healthcare data company providing clinical trial services and real-world evidence.
Booth
Exhibiting at Booth 1001
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
THRIVE-20-PF Spanish validation and a stepwise framework for psychometric evaluation and benchmarking in oncology
ePoster session 21
Gastrointestinal cancersNursing & supportive care
Satellite
Sun Oct 25
19:45–19:55
How Do Patient-Reported Outcomes Influence Reimbursement Decisions?
Regeneron - From Voice to Value: Advancing Actionable Patient- Reported Outcomes Evidence in Oncology
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at IQVIA

Tell us what you sell and we’ll find the people at IQVIA most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction